-
DoxyPEP: real-life effectiveness in a cohort of men who have sex with men in Milan, Italy Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-19 Angelo Roberto Raccagni, Sara Diotallevi, Riccardo Lolatto, Elena Bruzzesi, Gaia Catalano, Ilaria Mainardi, Chiara Maci, Caterina Candela, Camilla Muccini, Antonella Castagna, Silvia Nozza
No Abstract
-
Overcoming the global tuberculosis crisis with urgent country-level political and financial action Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-19 Suvanand Sahu, Lucica Ditiu, Rizwan Ahmed, Adam Zumla, Eleni Aklillu, Urvashi B Singh, Dorothy Yeboah-Manu, Danny Asogun, David S Hui, Alimuddin Zumla
No Abstract
-
Nipah virus research priorities: who sets them and for whom? Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-18 Md Zakiul Hassan, Anoop Kumar A S, Abu Faisal Md Pervez, Tahmina Shirin
No Abstract
-
The challenges of difficult-to-treat Acinetobacter infections Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2024-11-18 Guy A. RichardsOlga PerovicAdrian J. Brink1Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa2AMR Division at WITS Health Consortium, Pathologist Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses (CHARM), at the National Institute for Communicable Diseases, a division of NHLS and the University of the Witwatersrand, Johannesburg,
Clinical Microbiology Reviews, Ahead of Print.
-
A pan-orthoebolavirus neutralizing antibody encoded by mRNA effectively prevents virus infection. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-19 Pengfei Fan,Bingjie Sun,Zixuan Liu,Ting Fang,Yi Ren,Xiaofan Zhao,Zhenwei Song,Yilong Yang,Jianmin Li,Changming Yu,Wei Chen
Orthoebolavirus is a genus of hazardous pathogens that has caused over 30 outbreaks. However, currently approved therapies are limited in scope, as they are only effective against the Ebola virus and lack cross-protection against other orthoebolaviruses. Here, we demonstrate that a previously isolated human-derived antibody, 2G1, can recognize the glycoprotein (GP) of every orthoebolavirus species
-
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-19 Simon Valayer,Marie Alexandre,Mélanie Prague,Abdoul Habib Beavogui,Seydou Doumbia,Mark Kieh,Brian Greenwood,Bailah Leigh,Marie Poupelin,Christine Schwimmer,Samba O Sow,Irina Maljkovic Berry,Jens H Kuhn,Daniela Fusco,Natasha Dubois Cauwelaert,Deborah Watson-Jones,Rodolphe Thiébaut,Yves Lévy,Yazdan Yazdanpanah,Laura Richert,Edouard Lhomme,
rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination.Data from a large phase 2 randomized double-blind clinical trial (PREVAC) were used to evaluate waning of anti-Ebola virus (EBOV) glycoprotein (GP1
-
Unprecedented large outbreak of Plasmodium malariae malaria in Vietnam: Epidemiological and clinical perspectives. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-19 Chau Van Khanh,Hương Giang Lê,Tuấn Cường Võ,Nguyen Xuan Quang,Do Van Nguyen,Nguyen Cong Trung Dung,Le Thanh Tam,Nguyen Thanh Thuy Nhien,Đăng Thùy Dương Nguyễn,Thu Hằng Nguyễn,Tran Thi Hue Van,Le Duc Vinh,Pham Minh Quan,Nguyen Kim Trung,Jung-Mi Kang,Byoung-Kuk Na,Huynh Hong Quang
A significant outbreak of quartan malaria caused by Plasmodium malariae has occurred in Khanh Vinh District, Khanh Hoa Province, Vietnam in 2023 and the outbreak persists. In this report, we present the epidemiological and clinical characteristics of this extensive outbreak of quartan malaria in Vietnam.
-
Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-19 Joseph H Puyat, Sarah K Brode, Hennady Shulha, Kamily Romanowski, Dick Menzies, Andrea Benedetti, Raquel Duchen, Anjie Huang, Jiming Fang, Liane Macdonald, Ted K Marras, Elizabeth Rea, Jeffrey C Kwong, Michael A Campitelli, Jonathon R Campbell, Kevin Schwartzman, Victoria J Cook, James C Johnston
Background Tuberculosis (TB) incidence remains disproportionately high in people migrating to Canada and other low TB incidence countries, but systematic TB screening and prevention in migrants is often cost-prohibitive for TB programs. We aimed to develop and validate a TB risk prediction model to inform TB screening decisions in foreign-born permanent residents of Canada. Methods We developed and
-
Closing the gap in race-based inequities for seasonal influenza hospitalizations: a modeling study Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-19 Erin Stafford, Dobromir Dimitrov, Susan Brown Trinidad, Laura Matrajt
Background BIPOC (Black, Indigenous, and other People of Color) communities bear a disproportional burden of seasonal influenza hospitalizations in the United States. Methods We developed a race-stratified (5 racial-ethnic groups) agent-based model of seasonal influenza transmission and quantify the effects of 5 idealized interventions aimed at reducing inequities in symptomatic infections and hospitalizations
-
MiR-124-3p/EIF3B regulates host cell apoptosis induced by Chlamydia psittaci through PI3K/AKT signaling pathway J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-19 Ting Tong, Yunfei Li, You Zhou, Xindian Zeng, Cui Xiao, Saihong Cao, Chuan Wang, Zhongyu Li, Zhou zhou, Qinqin Bai, Shenghua Chen, Shuwu Yan, Lili Chen
Chlamydia psittaci is a zoonotic pathogen known to cause respiratory diseases in humans. Chlamydia infections are closely associated with apoptosis, in which miRNAs play regulatory roles. Herein, we demonstrated that C. psittaci infection induces apoptosis in human bronchial epithelial (HBE) cells and investigated regulatory mechanism involving miR-124-3p and the PI3K/AKT signaling pathway. Following
-
Compartmentalized HIV-1 reservoir in intestinal monocytes/macrophages on antiretroviral therapy J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-19 Camille Vellas, Dorine Martres, Mary Requena, Manon Nayrac, Nived Collercandy, Justine Latour, Karl Barange, Laurent Alric, Guillaume Martin-Blondel, Jacques Izopet, Bernard Lagane, Pierre Delobel
Background The persistence of latently infected cells prevents a cure of HIV. The intestinal mucosa contains numerous target cells, and high levels of HIV-1 DNA persist in this compartment under ART. While CD4+ T cells are the best characterized reservoir of HIV-1, the role of long-lived intestinal macrophages in HIV-1 persistence on ART remains controversial. Methods We collected duodenal and colonic
-
Umatilla Virus in Zoo-Dwelling Cape Penguins with Hepatitis, Germany Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-18 Monica Mirolo, Madeleine de le Roi, Katja von Dörnberg, Franziska Kaiser, Adnan Fayyad, Christina Puff, Ulrich Voigt, Ursula Siebert, Martin Ludlow, Wolfgang Baumgärtner, Albert Osterhaus
Analysis of liver tissue from a Cape penguin that died with hepatitis at a zoo in Germany revealed Umatilla virus. Testing uncovered Umatilla virus RNA in samples from 2 other deceased Cape penguins at the zoo. Our results expand knowledge of the prevalence of this virus in bird species across Germany.
-
Feline Panleukopenia Virus in a Marsican Brown Bear and Crested Porcupine, Italy, 2022–2023 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-18 Georgia Diakoudi, Gianvito Lanave, Shadia Berjaoui, Costantina Desario, Giovanni Di Teodoro, Violetta Iris Vasinioti, Francesco Pellegrini, Sabrina V.P. Defourny, Stefania Salucci, Antonio Cocco, Alessio Lorusso, Vito Martella, Nicola Decaro
The virus species Protoparvovirus carnivoran1 encompasses pathogens that infect both domestic and wild carnivores, including feline panleukopenia virus. We identified and characterized feline panleukopenia virus strains in a Marsican brown bear (Ursus arctos marsicanus) and a crested porcupine (Hystrix cristata) in Italy, extending the known host range of this virus.
-
Lobomycosis in Amazon Region, Bolivia, 2022 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-18 Maria I. Méndez, Rony Colanzi, Jose A. Suárez, Homero Penagos, Carolina Hernandez, Ruth Garcia-Redondo, Juan D. Ramirez, Alberto Paniz-Mondolfi
We report a patient with lobomycosis caused by Paracoccidioides loboi fungi in the Andes-Amazon region of Bolivia. We examined clinical, epidemiologic, and phylogenetic data and describe potential transmission/environmental aspects of infection. Continued surveillance and identification of lobomycosis cases in South America are crucial to prevent the spread of this disease.
-
The Trend, Prevalence and Potential Risk Factors of Secondary HIV Transmission among HIV/AIDS Individuals Receiving ART in Guangxi, China: a Longitudinal cross-sectional Study. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-18 Jinfeng He,Shanmei Zhong,Cai Qin,Aidan Nong,Zhaosen Lin,Huayue Liang,Fei Zhang,Jiaxiao Jiang,Peijiang Pan,Wudi Wei,Jie Liu,Deping Liu,Li Ye,Hao Liang,Bingyu Liang
Identifying the prevalence and risk factors of secondary human immunodeficiency virus (HIV) transmission from people living with HIV (PLWH) to other people is crucial for ending the HIV epidemic. However, the data among antiretroviral therapy (ART) patients is limited. This study aims to assess the prevalence and risk factors of secondary HIV transmission among PLWH receiving ART by longitudinal molecular
-
FGF8 protects against polymicrobial sepsis by enhancing the host's anti-infective immunity J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-18 Kai Chen, Yanting Ruan, Wenjing Ma, Xiaoyan Yu, Ying Hu, Yue Li, Hong Tang, Xuemei Zhang, Yibing Yin, Dapeng Chen, Zhixin Song
Background Sepsis is characterized by a life-threatening syndrome caused by an unbalanced host response to infection. Fibroblast Growth Factor 8 (FGF8) has been newly identified to play important roles in inflammation and innate immunity, but its role in host response to sepsis is undefined. Methods A cecal ligation and puncture (CLP) -induced mouse sepsis model was established to evaluate the immunomodulatory
-
Expansion of Oropouche virus in non-endemic Brazilian regions: analysis of genomic characterisation and ecological drivers Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-15 Tiago Gräf, Edson Delatorre, Caroline do Nascimento Ferreira, Agata Rossi, Hellen Geremias Gatica Santos, Bianca Ribeiro Pizzato, Valdinete Nascimento, Victor Souza, Gustavo Barbosa de Lima, Filipe Zimmer Dezordi, Alexandre Freitas da Silva, Clarice Neuenschwander Lins de Morais, Ighor Arantes, Mariza Hoffmann Machado, Darcita Buerger Rovaris, Mayra Marinho Presibella, Nelson Fernando Quallio Marques
BackgroundOropouche virus (OROV) is an arbovirus endemic in the Amazon region that closely resembles other arboviruses in terms of human disease, leading to potential misdiagnoses. The virus ecology has mostly restricted its occurrence to the Amazon biome; however, after a large 2023–24 OROV epidemic in the Brazilian Amazon region, outbreaks are being reported across Brazil and in other countries in
-
Probing Oropouche fever ecology beyond the Amazon Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-15 Ignacio Postigo-Hidalgo, Jan Felix Drexler
No Abstract
-
Mycobacterium leprae in Nine-Banded Armadillos (Dasypus novemcinctus), Ecuador Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-15 Daniel Romero-Alvarez, Manuel Calvopiña, Emily Cisneros-Vásquez, Daniel Garzon-Chavez, Alaine K. Warren, Lauren S. Bennett, Ritika R. Janapati, Carlos Bastidas-Caldes, Melanie Cabezas-Moreno, Jacobus H. de Waard, Daniela Silva-Martinod, Roxane Schaub, Mary Jackson, A. Townsend Peterson, Charlotte Avanzi
We found Mycobacterium leprae, the most common etiologic agent of Hansen disease or leprosy, in tissues from 9 (18.75%) of 48 nine-banded armadillos (Dasypus novemcinctus) collected across continental Ecuador. Finding evidence of a wildlife reservoir is the first step to recognizing leprosy zoonotic transmission pathway in Ecuador or elsewhere.
-
Effect of Sexual Partnerships on Zika Virus Transmission in Virus-Endemic Region, Northeast Brazil Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-15 Tereza Magalhaes, Flávio Codeço Coelho, Wayner V. Souza, Isabelle F.T. Viana, Thomas Jaenisch, Ernesto T.A. Marques, Brian D. Foy, Cynthia Braga
The epidemiologic effects of Zika virus (ZIKV) sexual transmission in virus-endemic countries remain unclear. We conducted a 2-level, linear mixed-effects logistic regression analysis by using a recently acquired population-based ZIKV and chikungunya virus (CHIKV) serologic dataset obtained from persons residing in Northeast Brazil (n = 2,070 participants). We adjusted mathematical models for housing
-
Clinical Manifestations, Antifungal Drug Susceptibility, and Treatment Outcomes for Emerging Zoonotic Cutaneous Sporotrichosis, Thailand Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-15 Pattriya Jirawattanadon, Sumanas Bunyaratavej, Charussri Leeyaphan, Piriyaporn Chongtrakool, Panitta Sitthinamsuwan, Waratchaya Panjapakkul, Suthasanee Prasertsook, Phuwakorn Saengthong-aram, Nicha Wareesawetsuwan, Julaluck Posri, Penvadee Pattanaprichakul
We analyzed clinical manifestations, antifungal susceptibility, and treatment outcomes of cutaneous sporotrichosis in Thailand during 2018–2022. The study included 49 patients whose mean age was 58.7 (SD 16.9) years; 65.3% were female and 34.7% male. A history of cat exposure was reported in 32 (65.3%) patients who had a significantly higher prevalence of upper extremity lesions than did those without
-
Historical Assessment and Mapping of Human Plague, Kazakhstan, 1926–2003 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-15 Nurkuisa Rametov, Ziyat Abdel, Zauresh Zhumadilova, Duman Yessimseit, Beck Abdeliyev, Raikhan Mussagaliyeva, Svetlana Issaeva, Omar F. Althuwaynee, Zhaksybek Baygurin, Kairat Tabynov
Understanding Kazakhstan’s plague history is crucial for early warning and effective health disaster management. We used descriptive-analytical methods to analyze spatial data for human cases in natural plague foci in Kazakhstan during 1926–2003. The findings revealed 565 human cases across 82 outbreaks in Almaty (32.22%), Aktobe (1.59%), Atyrau (4.42%), Mangystau (21.24%), and Kyzylorda (40.53%) oblasts
-
Adjunctive ivermectin mass drug administration for malaria control on the Bijagos Archipelago of Guinea-Bissau (MATAMAL): a quadruple-blinded, cluster-randomised, placebo-controlled trial Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-14 Harry Hutchins, Elizabeth Pretorius, John Bradley, Eunice Teixeira da Silva, Hristina Vasileva, Mamadou Ousmane Ndiath, Robert T Jones, Harouna dit Massire Soumare, Haddy Nyang, Aurelia Prom, Sarata Sambou, Fatima Ceesay, Sainey Ceesay, Sophie Moss, David Mabey, Paulo Djata, Jose Ernesto Nante, Cesario Martins, James G Logan, Hannah Slater, Anna Last
BackgroundArthropod vectors feeding on the blood of individuals treated with ivermectin have substantially increased mortality. Whether this effect will translate into a useful tool for reducing malaria burden at scale is not clear. Our trial aimed to assess whether using ivermectin as an adjunct to mass drug administration (MDA) with dihydroartemisinin–piperaquine would further reduce malaria prevalence
-
Is ivermectin surviving expectations in residual malaria control? Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-14 Karine Mouline, Carlo Costantini
No Abstract
-
Fatal Mixed Plasmodium Infection in Traveler Returning to Colombia from Comoros Islands, 2024 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-15 Leidy J. Medina-Lozano, Sergio Andrés Bolívar Lozano, Carolina Guavita, Milena Camargo, Luz Helena Patiño, Juan David Ramírez, Diana Carolina Gutiérrez-González, Álvaro A. Faccini-Martínez
During 2014–2022, only Plasmodium falciparum malaria cases were reported in the Comoro Islands. We report a fatal case of mixed Plasmodium malaria infection in a traveler returning from the Comoros to Colombia in 2024, highlighting the need to strengthen laboratory detection and identification of Plasmodium spp. in sub-Saharan Africa.
-
Laboratory detection of carbapenemases among Gram-negative organisms Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2024-11-15 Patricia J. SimnerJohann D. D. PitoutTanis C. Dingle1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA2Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA3Cummings School of Medicine, University of Calgary, Calgary, Calgary, Alberta, Canada4Alberta Precision Laboratories, Diagnostic Laboratory, Calgary, Alberta,
Clinical Microbiology Reviews, Ahead of Print.
-
Enriching the future of public health microbiology with hybridization bait capture Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2024-11-15 Megan S. BeaudryMohammad Imtiaj Uddin BhuiyanTravis C. Glenn1Department of Environmental Health Science, University of Georgia, Athens, Georgia, USA2Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA3Institute of Bioinformatics, University of Georgia, Athens, Georgia, USAGraeme N. Forrest
Clinical Microbiology Reviews, Ahead of Print.
-
Animal models for exploring Chagas disease pathogenesis and supporting drug discovery Clin. Microbiol. Rev. (IF 19.0) Pub Date : 2024-11-15 Archie A. KhanMartin C. TaylorAmanda Fortes FranciscoShiromani JayawardhanaRichard L. AthertonFrancisco OlmoMichael D. LewisJohn M. Kelly1Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United KingdomLouisa A. MessengerValeria Tekiel
Clinical Microbiology Reviews, Ahead of Print.
-
-
-
Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-15 Linzy V Rosen,Acadia M Thielking,Caitlin M Dugdale,Grace Montepiedra,Emma Kalk,Soyeon Kim,Sylvia M LaCourse,Jyoti S Mathad,Kenneth A Freedberg,C Robert Horsburgh,A David Paltiel,Robin Wood,Andrea L Ciaranello,Krishna P Reddy
BACKGROUND Although prior studies of tuberculosis-preventive treatment (TPT) for pregnant people with human immunodeficiency virus (PPWH) report conflicting adverse pregnancy outcome (APO) risks, international guidelines recommend TPT for PPWH. METHODS We used a microsimulation model to evaluate 5 TPT strategies among PPWH receiving antiretroviral therapy in South Africa: No TPT; 6 months of isoniazid
-
Annual Clinical and Economic Burden of Medically Attended Lower Respiratory Tract Illnesses Due to Respiratory Syncytial Virus among US Infants Aged <12 Months J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-15 Linnea Houde, Amy W Law, Ahuva Averin, Derek Weycker, Alejandro Cane, Sarah Pugh, Kimberly M Shea
We developed a model to project the expected annual clinical and economic burden of medically attended lower respiratory tract illnesses due to respiratory syncytial virus (RSV-LRTI) among US infants aged <12 months by combining information on population size, disease rates, mortality rates, and unit costs. Among the 3.7 million US infants aged <12 months each year, a total of 592,700 cases of RSV-LRTI
-
A potential platform for future vaccine trials identifies high incidence of symptomatic and asymptomatic influenza infection among children aged 6-23 months in South Africa J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-15 Cheryl Cohen, Mignon du Plessis, Neil Martinson, Jocelyn Moyes, Sibongile Walaza, Nicole Wolter, Mvuyo Makhasi, Fahima Moosa, Myrna Charles, Aaron M Samuels, Stefano Tempia, Tumelo Moloantoa, Bekiwe Ncwana, Louisa Phalatse, Amelia Buys, Alicia Fry, Eduardo Azziz Baumgartner, Anne von Gottberg, Jackie Kleynhans
Background Approaches for determining whether influenza vaccination prevents infection, attenuates illness, or both, are important for developing improved vaccines. We estimated influenza infection incidence, and evaluated symptom ascertainment methodologies in children to inform future vaccine trial design. Methods We conducted a prospective cohort study among children aged 6-23 months from May-October
-
Rio Mamore Hantavirus Endemicity, Peruvian Amazon, 2020 Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-13 Marta Piche-Ovares, Maria Paquita García, Andres Moreira-Soto, Maribel Dana Figueroa-Romero, Nancy Susy Merino-Sarmiento, Adolfo Ismael Marcelo-Ñique, Edward Málaga-Trillo, Dora Esther Valencia Manosalva, Miladi Gatty-Nogueira, César Augusto Cabezas Sanchez, Jan Felix Drexler
To explore hantavirus infection patterns in Latin America, we conducted molecular and serologic hantavirus investigations among 3,400 febrile patients from Peru during 2020–2021. Reverse transcription PCR indicated that a patient from Loreto, in the Peruvian Amazon, was positive for Rio Mamore hantavirus (3.8 × 103 copies/mL). High genomic sequence identity of 87.0%–94.8% and phylogenetic common ancestry
-
Human Circovirus in Patients with Hepatitis, Hong Kong Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-13 Shusheng Wu, Cyril Chik-Yan Yip, Jianwen Situ, Zhiyu Li, Stanley Siu-Fung Ho, Jianpiao Cai, Jane Hau-Ching Poon, Nicholas Foo-Siong Chew, Jonathan Daniel Ip, Tom Wai-Hin Chung, Kelvin Hei-Yeung Chiu, Anna Jinxia Zhang, Estie Hon-Kiu Shun, James Yiu-Hung Tsoi, Jade Lee-Lee Teng, David Christopher Lung, Kelvin Kai-Wang To, Vincent Chi-Chung Cheng, Irene Oi-Lin Ng, Kwok-Yung Yuen, Siddharth Sridhar
Circovirus human is a new viral species that includes the human circovirus (HCirV), which has been linked to hepatitis in immunocompromised persons. We investigated prevalence of HCirV infection in 278 patients with hepatitis and 184 asymptomatic persons using real-time PCR and sequencing assays. HCirV viremia and sequences were found in 8 (2.9%) hepatitis patients and no asymptomatic patients. Alternate
-
Increase in Adult Patients with Varicella Zoster Virus–Related Central Nervous System Infections, Japan Emerg. Infect. Dis. (IF 7.2) Pub Date : 2024-11-13 Ayami Yoshikane, Hiroki Miura, Sayuri Shima, Masaaki Matsunaga, Soichiro Ishimaru, Yuki Higashimoto, Yoshiki Kawamura, Kei Kozawa, Akiko Yoshikawa, Akihiro Ueda, Atsuhiko Ota, Hirohisa Watanabe, Tatsuro Mutoh, Tetsushi Yoshikawa
An increase in the number of herpes zoster patients has been reported since universal varicella immunization was introduced, perhaps because of reduced opportunities for varicella patients to experience the natural booster effect caused by reexposure. We investigated recent trends of varicella zoster virus (VZV)–related central nervous system (CNS) infections at a university hospital in Japan. We enrolled
-
Mycobacterium tuberculosis Antigen Rv1471 Induces Innate Immune Memory and Adaptive Immunity against Infection J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-14 Xuejiao Huang, Juan Wu, Jinchuan Xu, Huiling Wang, Zhenyan Chen, Xiao-Yong Fan, Zhidong Hu
Protein subunit vaccines form a key pipeline for developing novel tuberculosis (TB) vaccines. Mycobacterium tuberculosis (Mtb) contains approximately 4000 individual proteins. However, only approximately 100 have been evaluated as antigens in the clinical and preclinical stages of vaccine development. Trained immunity-targeting vaccines induce innate immune memory against heterologous infections and
-
Distribution of Clostridioides difficile ribotypes and sequence types across humans, animals and food in thirteen European countries. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-13 Rupnik Maja,Viprey Virginie,Janezic Sandra,Tkalec Valerija,Davis Georgina,Sente Béatrice,Devos Nathalie,Muller Bruno H,Santiago-Allexant Emmanuelle,Cleuziat Philippe,Wilcox Mark,Davies Kerrie,
Clostridioides difficile is a One Health pathogen found in humans, animals, and environment, with food representing a potential transmission route. One Health studies are often limited to single country or selected reservoirs and ribotypes. This study provides a varied and accessible collection of C. difficile isolates and sequencing data derived from human, animal, and food sources across thirteen
-
In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-13 Rebecca Grant,Marlieke E A de Kraker,Niccolò Buetti,Holly Jackson,Mohamed Abbas,Jonathan Aryeh Sobel,Rami Sommerstein,Marcus Eder,Carlo Balmelli,Nicolas Troillet,Peter W Schreiber,Philipp Jent,Laurence Senn,Domenica Flury,Sarah Tschudin-Sutter,Michael Buettcher,Maria Süveges,Laura Urbini,Olivia Keiser,Ursina Roder,Stephan Harbarth,Marie-Céline Zanella,
BACKGROUND As COVID-19 is integrated into existing infectious disease control programs, it is important to understand the comparative clinical impact of COVID-19 and other respiratory diseases. METHODS We conducted a retrospective cohort study of patients with symptomatic healthcare-associated COVID-19 or influenza reported to the nationwide, hospital-based surveillance system in Switzerland. Included
-
Oral antibiotics for S. aureus bacteremia including endocarditis: sauce for the goose is sauce for the gander. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-13 Todd C Lee,Brad Spellberg,Emily G McDonald
-
Generalizability of oral therapy for S. aureus bacteremia or endocarditis: don't cook the goose. Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-13 Ahmad Mourad,Thomas L Holland,Timothy C Jenkins
-
Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017-2023 Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-13 Elena Ferran, Cathleen Chan, Noorann Sheikh, Martin Dedicoat, Eliza Alexander, Ana Gibertoni-Cruz, James Brown, Esther Robinson, Marc Lipman
Fluoroquinolones are an important component of anti-tuberculosis treatment and identifying fluoroquinolone resistance is essential. We present the first survey of fluoroquinolone resistance in England from sequencing of over 16,000 unselected isolates. Fluoroquinolone resistance was 1.4% overall and 23.9% in multidrug-resistant TB. Routine sequencing allows resistance surveillance and should be widely
-
Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-13 Rachel L Epstein, Sarah Munroe, Lynn E Taylor, Patrick R Duryea, Benjamin Buzzee, Tannishtha Pramanick, Jordan J Feld, Dimitri Baptiste, Matthew Carroll, Laurent Castera, Richard K Sterling, Aurielle Thomas, Philip A Chan, Benjamin P Linas
Background Liver disease assessment is a key aspect of chronic hepatitis C virus (HCV) infection pre-treatment evaluation but guidelines differ on the optimal testing modality given trade-offs in availability and accuracy. We compared clinical outcomes and cost-effectiveness of common fibrosis staging strategies. Methods We simulated adults with chronic HCV receiving care at US health centers through
-
Real-World Application of the MeMed BV Test in Differentiating Bacterial, Viral, and Mycoplasma pneumoniae Infections in Pediatric Community-Acquired Pneumonia. J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-13 Marco Denina,Carlo Maria Minero,Raffaele Vitale,Cecilia Maria Pini,Matteo Operti,Silvia Garazzino,Claudia Bondone
-
Epidemiologic and genomic characterization of an outbreak of Rift Valley fever among humans and dairy cattle in northern Tanzania J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-13 Deng B Madut, Matthew P Rubach, Kathryn J Allan, Kate M Thomas, William A de Glanville, Jo E B Halliday, Cristina Costales, Manuela Carugati, Robert J Rolfe, John P Bonnewell, Michael J Maze, Alex R Mremi, Patrick T Amsi, Nathaniel H Kalengo, Furaha Lyamuya, Grace D Kinabo, Ronald Mbwasi, Kajiru G Kilonzo, Venance P Maro, Blandina T Mmbaga, Bingileki Lwezaula, Calvin Mosha, Annette Marandu, Tito J
Background A peri-urban outbreak of Rift Valley fever virus (RVFV) among dairy cattle from May through August 2018 in northern Tanzania was detected through testing samples from prospective livestock abortion surveillance. We sought to identify concurrent human infections, their phylogeny, and epidemiologic characteristics in a cohort of febrile patients enrolled from 2016-2019 at hospitals serving
-
An antimicrobial blue light prototype device controls infected wounds in a preclinical porcine model J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-13 Laisa Bonafim Negri, William Farinelli, Sandeep Korupolu, Ying Wang, Yara Mannaa, Hang Lee, Jie Hui, Pu-Ting Dong, Andrea Slate, Joshua Tam, R Rox Anderson, Seok-Hyun Andy Yun, Jeffrey A Gelfand
We developed a translational prototype antimicrobial blue light (ABL) device for treating skin wounds with ABL. Partial-thickness surgical wounds were created in live swine, an animal whose skin is considered the most like human skin, then heavily contaminated and left untreated for 24 hours with methicillin-resistant Staphylococcus aureus (MRSA). ABL treatment stabilized and reduced MRSA infection
-
The synergistic effect between phages and Ceftolozane/Tazobactam in Pseudomonas aeruginosa endotracheal tube biofilm. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-17 Viviane de C Oliveira,Alba Soler-Comas,Amanda C S D Rocha,Cláudia H Silva-Lovato,Evandro Watanabe,Antoni Torres,Laia Fernández-Barat
Although an increased effectiveness has been suggested when phages and antibiotics are combined, this approach has not been tested against a mature biofilm on an endotracheal tube (ETT) surface. This study evaluated the effect of short- and long-term combined phage-antibiotic therapy in a control of a mature biofilm on an ETT surface. Pseudomonas aeruginosa strains, including susceptible and resistant
-
Analytical and clinical evaluation of a duplex RT-qPCR assay for the detection and identification of o'nyong-nyong and chikungunya virus. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-12 Konrad M Wesselmann,Lea Luciani,Laurence Thirion,Xavier de Lamballerie,Remi Charrel,Laura Pezzi
The mosquito-borne alphavirus o'nyong-nyong virus (ONNV) has proven its potential to cause major human outbreaks. On the African continent, ONNV causes unspecific febrile illness and co-circulates with the close relative chikungunya virus (CHIKV). The true scale of ONNV burden is poorly understood in Africa, because of the scarce availability of molecular in-house and commercial assays, strong cross-reactivity
-
Influenza neuraminidase mutations and resistance to neuraminidase inhibitors. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-12 Jiapeng Xu,Qiting Luo,Yuanyuan Huang,Jieyu Li,Wei Ye,Ran Yan,Xinrui Zhou,Zhendan He,Ge Liu,Qinchang Zhu
Mutations in influenza virus neuraminidase (NA) can lead to viral resistance to NA inhibitors (NAIs). To update global influenza NA mutations and resistance to NAIs, we investigated epidemic information from global regions for NAIs-resistant influenza strains and analyzed their NA mutations. Drug-resistant mutations in NA, especially new mutations occurred in 2016-2024, were updated. The H274Y mutation
-
Unbiased phage display screening identifies hidden malaria vaccine targets. Emerg. Microbes Infect. (IF 8.4) Pub Date : 2024-11-12 Marcelo Jacobs-Lorena,Sung-Jae Cha
AbstractMalaria is among the deadliest infectious diseases. Over 200 million annual clinical malaria cases are reported and more than half a million people, mostly children, die every year. The most advanced RTS,S/AS01 vaccine based on the P. falciparum circumsporozoite protein (CSP), targets sporozoite liver infection but achieved modest efficacy. To reduce malaria death, novel malaria vaccine development
-
Long-Acting Cabotegravir Plus Rilpivirine in People with HIV with Adherence Challenges and Viremia: Current Data and Future Directions Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-12 Jennifer M Davis, Aadia Rana, Paul E Sax, Sara H Bares
Long-acting injectable cabotegravir plus rilpivirine (LA CAB/RPV) is currently US Food and Drug Administration (FDA)-approved and HIV treatment guideline-endorsed as a switch strategy for patients with HIV (PWH) who are virologically suppressed on oral ART without a history of treatment failure. Recent changes to the International Antiviral Society-USA (IAS-USA) and U.S. Department of Health and Human
-
Association of mRNA COVID-19 vaccination and reductions in Post-COVID Conditions following SARS-CoV-2 infection in a US prospective cohort of essential workers J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-12 Josephine Mak, Sana Khan, Amadea Britton, Spencer Rose, Lisa Gwynn, Katherine D Ellingson, Jennifer Meece, Leora Feldstein, Harmony Tyner, Laura Edwards, Matthew S Thiese, Allison Naleway, Manjusha Gaglani, Natasha Solle, Jefferey L Burgess, Julie Mayo Lamberte, Meghan Shea, Taryn Hunt-Smith, Alberto Caban-Martinez, Cynthia Porter, Ryan Wiegand, Ramona Rai, Kurt T Hegmann, James Hollister, Ashley Fowlkes
Background While there is evidence that COVID-19 vaccination protects against development of post-COVID conditions (PCC) after severe infection data are limited on whether vaccination reduces the risk after cases of less-severe non-hospitalized COVID-19 disease with more recent SARS-CoV-2 variant viruses. This study assessed whether COVID-19 vaccination was protective against subsequent development
-
Asymptomatic Cerebrospinal Fluid HIV-1 Escape: Incidence and Consequences J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-12 Gustaf Ulfhammer, Aylin Yilmaz, Åsa Mellgren, Erika Tyrberg, Erik Sörstedt, Lars Hagberg, Johanna Gostner, Dietmar Fuchs, Henrik Zetterberg, Staffan Nilsson, Kristina Nyström, Arvid Edén, Magnus Gisslén
Background The incidence and clinical relevance of asymptomatic cerebrospinal fluid escape (CSF-E) during antiretroviral therapy (ART) is uncertain. We examined the impact and incidence of asymptomatic CSF-E in a Swedish HIV cohort. Methods Neuroasymptomatic people living with HIV (PLWH) who have been on ART for at least six months with suppressed plasma viral load were followed longitudinally. CSF-E
-
Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-11 Jiaqi Pu, Shouquan Wu, Jian-Qing He
Introduction The efficacy and safety of corticosteroids in patients with human immunodeficiency virus (HIV) and tuberculosis (TB) remain controversial. Method PubMed, Embase, Web of Science, and the Cochrane Database were searched on September 19, 2024. The primary outcome was all-cause mortality, while secondary outcomes included serious adverse events. A random-effects model calculated risk ratios
-
Alleviation of COVID-19 Symptoms and Reduction in Healthcare Utilization Among High-Risk Patients Treated With Nirmatrelvir/Ritonavir (NMV/R): A phase 3 randomized trial Clin. Infect. Dis. (IF 8.2) Pub Date : 2024-11-11 Jennifer Hammond, Heidi Leister-Tebbe, Annie Gardner, Paula Abreu, Weihang Bao, Wayne Wisemandle, Wajeeha Ansari, Magdalena Alicja Harrington, Abraham Simón-Campos, Kara W Chew, Rienk Pypstra, James M Rusnak
Background Nirmatrelvir/ritonavir (NMV/r) is an oral antiviral treatment for mild to moderate COVID-19. Methods This phase 2/3, double-blind, randomized (1:1) study assessed oral NMV/r 300 mg/100 mg versus placebo every 12 hours for 5 days in high-risk, unvaccinated, nonhospitalized, symptomatic adults with COVID-19 from 343 sites across 21 countries. In testing the primary endpoint of COVID-19‒related
-
Gilead under fire over HIV drug licensing Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-08 Ed Holt
No Abstract
-
The dangers of medication sharing at private sex parties Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-08 Matthew J Mimiaga, Nina T Harawa
No Abstract
-
Antimicrobial resistance among refugees and asylum seekers: a global systematic review and meta-analysis Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-08 Elizabeth D Hermsen, James Amos, Andy Townsend, Thomas Becker, Sally Hargreaves
Refugees and asylum seekers might have an increased risk of antimicrobial resistance (AMR) carriage or infection due to several factors, with conflict and war known to accelerate the spread of AMR. However, data are scarce on prevalence and risk factors for AMR among refugees and asylum seekers and how they are affected globally; in addition, how their risk compares to that of the host-country population
-
Fitness of SARS-CoV-2 Omicron subvariants in respiratory and gastrointestinal cell lines as determined by RT-ddPCR and whole genome sequencing J. Infect. Dis. (IF 5.0) Pub Date : 2024-11-09 Mathilde Hénaut, Julie Carbonneau, Inès Levade, Guy Boivin
The fitness of SARS-CoV-2 Omicron subvariants was determined in human epithelial and continuous cells of the respiratory and gastrointestinal tracts. Competition experiments over 4 days were performed followed by quantification of variant ratios by reverse transcription-droplet digital PCR. These quantitative data were correlated with whole genome sequencing. In competition experiments of two subvariants
-
Research and product development for Crimean–Congo haemorrhagic fever: priorities for 2024–30 Lancet Infect Dis (IF 36.4) Pub Date : 2024-11-07 Amanda E Semper, Janie Olver, Jenny Warner, Ana Cehovin, Petra C Fay, Peter J Hart, Josephine P Golding, Virginia Benassi, Marie-Pierre Preziosi, Khdair Hazbar Razzaq Al-Asadi, Lucille H Blumberg, José de la Fuente, Nazif Elaldi, Tom Fletcher, Pierre B H Formenty, Mohammad Mehdi Gouya, Stephan Günther, Roger Hewson, Bushra Jamil, Gary Kobinger, Timothy J G Brooks
Crimean–Congo haemorrhagic fever (CCHF) is a widely distributed and potentially fatal tick-borne viral disease with no licensed specific treatments or vaccines. In 2019, WHO published an advanced draft of a research and development roadmap for CCHF that prioritised the development and deployment of the medical countermeasures most needed by CCHF-affected countries. This Personal View presents updated